Emma McAlister
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Emma McAlister has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Eneko Larrañeta
School of Pharmacy, Queen's University Belfast, Lisburn Road 97, Belfast BT9 7BL, UK
2 shared publications - Juan Domínguez-Robles
Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Sevilla, 41012 Seville, Spain
2 shared publications - Ryan F. Donnelly
School of Pharmacy, Queen’s University Belfast, Belfast, UK
2 shared publications Aaron R.J. Hutton
School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, United Kingdom
1 shared publication- Abigail Bogan
School of Pharmacy, Queen’s University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK
1 shared publication - Alejandro Javier Paredes
School of Pharmacy, Queen’s University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, U.K.
1 shared publication
Latest Publications
- 1 August 2021
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 175, 113825
The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosis
- 1 August 2021
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 175, 113825
The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosis
- Open Access
- 30 May 2020
- Published by MDPI AG in Micromachines
- Vol. 11 (6) , 554
Novel Design Approaches in the Fabrication of Polymeric Microarray Patches via Micromoulding
The focus on novel systems for transdermal delivery of therapeutic agents has increased considerably over recent years, as this administration route comes with many advantages. Polymeric microarray patches (MAPs) are minimally invasive devices that enable systemic delivery of a wide range of drugs by overcoming the outer skin barrier. Conventionally, MAPs fabricated by micromoulding have a low needle density. In this study, the performance of hydrogel-forming MAPs cast using novel industrially manufactured micromoulds with a high needle density (600 needles/0.75 cm2) was compared to that of MAPs obtained using conventional moulds with a lower density (196 needles/0.89 cm2). Surrounding holders for micromoulds were designed for time-efficient fabrication of MAPs. The influence of needle densities on mechanical strength, insertion efficiency and in vitro permeation of ibuprofen sodium (IBU) was analysed. Insertion of both MAPs into an artificial skin model and neonatal porcine skin was comparable. No significant difference was observed in permeation studies of IBU (p > 0.05), with a delivery of 8.7 ± 1.7 mg for low-density and 9.5 ± 0.1 mg for high-density MAPs within 24 h. This highlights the potential of these novel micromoulds for manufacturing polymeric MAPs with a higher needle density for future applications.
- 30 May 2020
- Published by MDPI AG in Micromachines
- Vol. 11 (6) , 554
Open AccessNovel Design Approaches in the Fabrication of Polymeric Microarray Patches via Micromoulding
The focus on novel systems for transdermal delivery of therapeutic agents has increased considerably over recent years, as this administration route comes with many advantages. Polymeric microarray patches (MAPs) are minimally invasive devices that enable systemic delivery of a wide range of drugs by overcoming the outer skin barrier. Conventionally, MAPs fabricated by micromoulding have a low needle density. In this study, the performance of hydrogel-forming MAPs cast using novel industrially manufactured micromoulds with a high needle density (600 needles/0.75 cm2) was compared to that of MAPs obtained using conventional moulds with a lower density (196 needles/0.89 cm2). Surrounding holders for micromoulds were designed for time-efficient fabrication of MAPs. The influence of needle densities on mechanical strength, insertion efficiency and in vitro permeation of ibuprofen sodium (IBU) was analysed. Insertion of both MAPs into an artificial skin model and neonatal porcine skin was comparable. No significant difference was observed in permeation studies of IBU (p > 0.05), with a delivery of 8.7 ± 1.7 mg for low-density and 9.5 ± 0.1 mg for high-density MAPs within 24 h. This highlights the potential of these novel micromoulds for manufacturing polymeric MAPs with a higher needle density for future applications.